share_log

Bright Minds Biosciences | 6-K: Bright Minds Biosciences Initiates the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy

Bright Minds Biosciences | 6-K: Bright Minds Biosciences Initiates the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy

Bright Minds Biosciences | 6-K:Bright Minds Biosciences启动突破性研究:Bmb-101治疗失神性癫痫和发育性癫痫性脑病2期试验
美股SEC公告 ·  2024/09/13 01:03
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息